Complement, thrombotic microangiopathy and disseminated intravascular coagulation [PDF]
, 2014 core +1 more source
Convalescent Plasma for Ebola Virus Disease [PDF]
, 2016 Fischer, William +2 more
core +5 more sources
MASP2 levels are elevated in thrombotic microangiopathies: association with microvascular endothelial cell injury and suppression by anti-MASP2 antibody narsoplimab. [PDF]
Clin Exp Immunol, 2021 Elhadad S +5 more
europepmc +1 more source
The Interaction Between Coagulation and Complement Cascades in the Management of Thrombotic Microangiopathies Related to Postpartum Hemorrhage. [PDF]
Kidney Int RepOrsi M, Ossola MW, Cetin I, Ardissino G.
europepmc +1 more source
Complement activation in thrombotic thrombocytopenic purpura [PDF]
, 2014 Alvarez-Larran +28 more
core +1 more source
Unfavorable course in pregnancy-associated thrombotic thrombocytopenic purpura necessitating a perimortem Cesarean section: a case report [PDF]
, 2013 core +1 more source
Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS): a 24-year clinical experience with 178 patients [PDF]
core +1 more source
HLA-DR-DQ associations, combined with PLASMIC score, are reliable predictors of acquired thrombotic thrombocytopenic purpura (aTTP) and aid in differentiating aTTP from other thrombotic microangiopathies. [PDF]
Hematol Transfus Cell TherPandey S +4 more
europepmc +1 more source
When to consider targeted therapies in thrombotic microangiopathies in the modern era: walking the tightrope between cost, safety, and efficacy. [PDF]
J Thromb Thrombolysis, 2020 Murphree CR +3 more
europepmc +1 more source